Estrogen-induced Ets-1 promotes capillary formation in an in vitro tumor angiogenesis model

Breast Cancer Research and Treatment

Volumn 78, Issue 2, 2003, Pages 167-178

  Lincoln II, David W ^a   Phillips, Patricia G ^a   Bove, Kathleen ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b STRATTON VA MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Endothelial cell; Estrogen; Ets 1; Mammary tumor

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELL PROTEIN; ESTRADIOL; ESTROGEN; FULVESTRANT; INTEGRIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROGESTERONE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR ETS 1; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; AORTA; ARTICLE; BREAST TUMOR; CAPILLARY PROLIFERATION; CELL INVASION; CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; GENETIC TRANSFECTION; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TUMOR CELL CULTURE; TUMOR MODEL; TUMOR VASCULARIZATION; UPREGULATION;

ANIMALS; CAPILLARIES; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GENE EXPRESSION; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 9; MICE; MODELS, ANIMAL; MODELS, CARDIOVASCULAR; NEOVASCULARIZATION, PATHOLOGIC; PROGESTERONE; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RATS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 0037358574     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022904624054     Document Type: Article

References (29)

1. Folkman JM, Long D, Becker FF: Growth and metastasis of tumor in organ culture. Cancer 16: 453-467, 1963
2. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis: Correlation in invasive breast cancer. N Eng J Med 5: 1-8, 1991
3. Weidner N: Intratumoral microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19, 1995
4. Obermair A, Kurz C, Czerwenka K, Thoma M, Kaider A, Wagner T, Gitsch G, Sevelda P: Microvessel density and vessel invasion in lymph-node negative breast cancer: effect on recurrence-free survival. Int J Cancer 62: 126-131, 1995
5. Ryan CJ, Wilding G: Angiogenesis inhibitors. New agents in cancer therapy. Drugs Aging 17: 249-255, 2000
6. Rosen L: Antiangiogenic strategies and agents in clinical trials. Oncologist 5: 20-27, 2000
7. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK, Schnaper HW: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91: 755-763, 1995
8. Concina P, Sordello S, Barbacanne M, Elhage R, Pieraggi M, Fournial G, Plouet J, Bayard F, Arnal JF: The mitogenic effect of 17-estradiol on in vitro EC proliferation and on in vivo reendothelialization are both dependent on vascular endothelial growth factor. J Vasc Res 7: 202-208, 2000
9. Torossov MT, Hrushesky WJM, Gupta H, Mann G, Vyzula R, Wood PA: Fertility cycle dependent tumor growth nonlinearity unmasked. Proc Am Assoc Cancer Res 36: 38-46, 1995
10. Phillips P, Birnby L, Narendran A, Milonovich WL: Nitric oxide modulates capillary formation at the endothelial cell/tumor cell interface. Am J Physiol: L278-L290, 2001
11. Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T, Kuroiwa Y: Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with Ets-1 in ECs. Life Sci 64: 249-258, 1999
12. Lincoln DW, Hrushesky WJM, Wood PA: Circadian organization of thymidylate synthase activity in normal tissues: a possible basis for 5-fluorouracil chronotherapeutic advantage. Int J Cancer 88: 479-485, 2000
13. Valter MM. Hugel A, Juang H-JS, Cavanee WK, Wiestler OD, Pietsch T, Wernert N: Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Fit-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 59: 5608-5614, 1999
14. Risau W: Differentiation of endothelium. FASEB 9: 926-933, 1995
15. Losordo DW, Isner JM: Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol 21: 6-12, 2001
16. Vazquez F, Rodriguez-Manzaneque JC, Lydon JP, Edwards DP, O'Malley BW, Iruela-Arispe ML: Progesterone regulates proliferation of endothelial cells. J Biol Chem 274(4): 2185-2192, 1999
17. Wasylyk B, Hahn SL, Giovane A: The Ets family of transcription factors. Eur J Biochem 211: 7-18, 1993
18. Gutman A, Wasylyk B: The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9: 2241-2246, 1990
19. Wernert N, Raes MB, Lassalle P. Dehouck MP, Gosselin B, Vandenbunder B, Stehelin D: C-ets-1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 140: 119-127, 1992
20. Oda N, Abe M, Sato Y: Ets-1 converts ECs to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin 3. J Cell Physiol 178: 121-132, 1999
21. Nakayama T, Ito M, Ohtsuru A, Naito S, Nakashima M, Fagin JA, Yamashita S, Sekine I: Expression of the Ets-proto-oncogene in human gastric carcinoma. Correlation with tumor invasion. Am J Pathol 149: 1931-1939, 1996
22. Gilles C, Polette M, Birembaut P, Brunner N, Thompson EN: Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines. Clin Exp Metastasis 15: 519-526, 1997
23. Bolon I, Gouyer V. Devouassoux M, Vandenbunder B, Wernert N. Moro D, Brambilla C, Brambilla E: Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 147: 1298-1310, 1995
24. Chen Z, Fisher R, Li B: Elevated expression of ETS-1 gene in a metastatic, tumorigenic human prostate epithelial cell line transformed by the v-Ki-ras oncogene. Int J Oncol 11: 1179-1184, 1997
25. Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM: Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin Cancer Res 7: 451-453, 2001
26. Saeki H, Kuwano H, Kawaguchi H, Ohno S, Sugimachi K: Expression of Ets-1 transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus. Cancer 89: 1670-1676, 2000
27. Fong G-H, Rossant J, Gertsenstein M, Breitman ML: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70, 1995
28. Peters KG, DeVries C. Williams LT: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90: 8915-8919, 1993
29. Oda N, Abe M, Sato Y: Ets-1 converts ECs to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3. J Cell Physiol 178: 121-132, 1999